...
首页> 外文期刊>The Journal of Organic Chemistry >Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal alpha-Glucosidases: Binding Conformation and Interaction for ntSI
【24h】

Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal alpha-Glucosidases: Binding Conformation and Interaction for ntSI

机译:Labbystegines、来自乳酸菌和花萼的杂交亚氨基糖作为肠道 α-葡萄糖苷酶抑制剂的设计和合成:ntSI 的结合构象和相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

This paper identifies the required configuration and orientation of alpha-glucosidase inhibitors, miglitol, alpha-1-C-butyl-DNJ, and alpha-1-C-butyl-LAB for binding to ntSI (isomaltase). Molecular dynamics (MD) calculations suggested that the flexibility around the keyhole of ntSI is lower than that of ctSI (sucrase). Furthermore, a molecular-docking study revealed that a specific binding orientation with a CH-pi interaction (Trp370 and Phe648) is a requirement for achieving a strong affinity with ntSI. On the basis of these results, a new class of nortropane-type iminosugars, labystegines, hybrid iminosugars of LAB and calystegine, have been designed and synthesized efficiently from sugar-derived cyclic nitrones with intramolecular 1,3-dipolar cycloaddition or samarium iodide catalyzed reductive coupling reaction as the key step. Biological evaluation showed that our newly designed 3(S)-hydroxy labystegine (6a) inherited the selectivity against intestinal alpha-glucosidases from LAB, and its inhibition potency was 10 times better than that of miglitol. Labystegine, therefore, represents a promising new class of nortropane-type iminosugar for improving postprandial hyperglycemia.
机译:本文确定了 α-葡萄糖苷酶抑制剂米格列醇、α-1-C-丁基-DNJ 和 α-1-C-丁基-LAB 与 ntSI(异麦芽糖酶)结合所需的构型和取向。分子动力学(MD)计算表明,ntSI锁孔周围的柔韧性低于ctSI(蔗糖酶)。此外,一项分子对接研究表明,具有 CH-pi 相互作用(Trp370 和 Phe648)的特定结合取向是实现与 ntSI 强亲和力的必要条件。基于这些结果,以分子内1,3-偶极环加成或碘化钐催化的还原偶联反应为关键步骤,设计了一类新型的去甲曲烷型亚氨基糖,即Lab和calystegine的杂化亚氨基糖。生物学评价表明,我们新设计的3(S)-羟基迷宫苷(6a)继承了乳酸菌对肠道α-葡萄糖苷酶的选择性,其抑制效力是米格列醇的10倍。因此,Labystegine 代表了一类有前途的新型去甲曲烷型亚氨基糖,用于改善餐后高血糖。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号